| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/14/2011 | WO2011012254A8 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
| 04/14/2011 | WO2011009058A3 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 04/14/2011 | WO2010030979A3 Targeting pathogenic monocytes |
| 04/14/2011 | WO2009116984A3 Highly thermostable fluorescent proteins |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110088128 Polypeptide extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi |
| 04/14/2011 | US20110088104 Novel antibodies for the treatment of hiv |
| 04/14/2011 | US20110087007 Cytokine-Like Proteins |
| 04/14/2011 | US20110087002 Methods for Cyclizing Synthetic Polymers |
| 04/14/2011 | US20110086803 Peptides containing tryptophan |
| 04/14/2011 | US20110086391 Expression Vector |
| 04/14/2011 | US20110086390 Product and Process for Transformation of Thraustochytriales Microorganisms |
| 04/14/2011 | US20110086389 Compositions and Methods for Expressing In-Frame Multimeric Proteins |
| 04/14/2011 | US20110086388 Chaperone-assisted protein expression and methods of use |
| 04/14/2011 | US20110086387 Mutant nanoarchaeum equitans a523r dna polymerase and its use |
| 04/14/2011 | US20110086386 Algae biomass fractionation |
| 04/14/2011 | US20110086345 Isolation and use of ryanodine receptors |
| 04/14/2011 | US20110086131 Lipolytic enzyme: uses thereof in the food industry |
| 04/14/2011 | US20110086059 Non-hemolytic clya for excretion of proteins |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086026 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 04/14/2011 | CA2776748A1 Use of pedf in an encapsulated cell-based delivery system |
| 04/14/2011 | CA2776385A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
| 04/13/2011 | EP2309264A1 Device for detection of influenza virus |
| 04/13/2011 | EP2308987A2 Improved transfection of eukaryotic cells with linear polynucleotides by electroporation |
| 04/13/2011 | EP2308985A2 Plastid genetic engineering via somatic embryogenesis |
| 04/13/2011 | EP2308975A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 04/13/2011 | EP2308974A2 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 04/13/2011 | EP2308973A1 Method to screen phage display libraries with different ligands |
| 04/13/2011 | EP2308968A1 Compositions and methods for the treatment of immune related diseases |
| 04/13/2011 | EP2308890A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/13/2011 | EP2308888A1 Anti-IL-6 antibodies, compositions, methods and uses |
| 04/13/2011 | EP2308502A1 Method to induce neovascular formation and tissue regeneration |
| 04/13/2011 | EP2307441A1 A process for preparation of insulin compounds |
| 04/13/2011 | CN1763097B Polypeptide variants with altered effector function |
| 04/13/2011 | CN102016059A Treatment and prophylaxis of amyloidosis |
| 04/13/2011 | CN102016058A Methods and compositions related to peptides and proteins with C-terminal elements |
| 04/13/2011 | CN102016057A Method of denaturing protein with enzymes |
| 04/13/2011 | CN102016047A Host cells and methods of producing disulfide bond containing proteins |
| 04/13/2011 | CN102016042A Isolated peptides having phospholipase inhibitory activity |
| 04/13/2011 | CN102016025A Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof |
| 04/13/2011 | CN102014956A PSMA binding ligand-linker conjugates and methods for using |
| 04/13/2011 | CN102014656A Method for production of defatted soymilk peptide |
| 04/13/2011 | CN102014623A Producing biofuels using polyketide synthases |
| 04/13/2011 | CN102010884A Antibacterial active matter as well as preparation method and application thereof |
| 04/13/2011 | CN102010875A Method for preparing biotinylated protein |
| 04/13/2011 | CN102010471A Interleukin-10 antibodies |
| 04/13/2011 | CN102010460A Tea seed polypeptide and preparation method thereof |
| 04/13/2011 | CN101307348B Method for preparing undenatured collagen from fish scale of fresh water fish |
| 04/13/2011 | CN101076716B An apparatus for and method of sampling and collecting powders flowing in a gas stream |
| 04/12/2011 | US7923539 IL-21 antagonists |
| 04/12/2011 | US7923538 Recombinant antibody composition |
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923534 Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3 |
| 04/12/2011 | US7923430 Methods for producing modified glycoproteins |
| 04/12/2011 | US7923236 Fungal enzymes |
| 04/12/2011 | US7923231 Production of glucuronic acid using myo-inositol oxygenase from cryptococcus neoformans |
| 04/12/2011 | US7923221 Methods of making antibody heavy and light chains having specificity for a desired antigen |
| 04/12/2011 | US7923220 Process for preparing high levels of interferon beta |
| 04/12/2011 | US7923208 Using presence of variation in Zcytor16 gene sequences as evaluative tool in diagnosis of cell proliferative disorders |
| 04/12/2011 | US7923017 Modified Vaccinia Ankara virus variant |
| 04/12/2011 | US7923012 Immunizing an animal using polypeptide; amino acid sequences; controlling phosphate, vitamin D metabolism |
| 04/12/2011 | US7923011 Antibodies to lymphotoxin-alpha |
| 04/12/2011 | US7923008 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
| 04/12/2011 | US7922483 Method of using a polynucleotide encoding 2.5-diketo-D-gluconic acid reductase |
| 04/12/2011 | CA2456172C Kidney-specific urate transporter and uses thereof |
| 04/12/2011 | CA2400908C Fusion protein having enhanced in vivo erythropoietin activity |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2354153C Compounds and methods for modulating activation of nf-.kappa.b |
| 04/12/2011 | CA2311409C Treatment with anti-erbb2 antibodies |
| 04/12/2011 | CA2050318C Endothelial cell growth factor, methods of isolation and expression |
| 04/07/2011 | WO2011041594A1 Recombinant c1 b-glucosidase for production of sugars from cellulosic biomass |
| 04/07/2011 | WO2011041518A1 Monoclonal antibodies |
| 04/07/2011 | WO2011041327A1 Light controlled protein dimerization in cells |
| 04/07/2011 | WO2011040429A1 Monoclonal antibody against human hig-1 polypeptide |
| 04/07/2011 | WO2011040133A1 Human serum amyloid-a3 antibody and use thereof |
| 04/07/2011 | WO2011039721A1 New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody |
| 04/07/2011 | WO2011039156A1 Process for producing cysteine and/or glutathione from cystine employing yeast |
| 04/07/2011 | WO2011038575A1 Novel antibody treatment |
| 04/07/2011 | WO2011002968A3 Polypeptides and method of treatment |
| 04/07/2011 | US20110082285 Transgenic rodents having ngf beta gene mutants and its preparation methods, the preparation methods of the corresponding mutant proteins and the resulting mutant proteins |
| 04/07/2011 | US20110082282 Process of preparing conjugates of allium organosulfur compounds with amino acids, peptides, and proteins |
| 04/07/2011 | US20110082281 Casein hydrolyzate, process for producing the same and use thereof |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110082052 Phage displaying system expressing single chain antibody |
| 04/07/2011 | US20110081705 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 04/07/2011 | US20110081682 Production of bone morphogenic proteins (bmps) using a novel tissue culture platform |
| 04/07/2011 | US20110081681 Human antibodies to human cd20 and method of using thereof |
| 04/07/2011 | US20110081680 Animal Protein-Free Media For Cultivation of Cells |
| 04/07/2011 | US20110081679 Mammalian cell culture processes for protein production |
| 04/07/2011 | US20110081678 Method for producing beta-alanyl-amino acid or derivative thereof |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081642 Selection of B Cells with Specificity of Interest: Method of Preparation and Use |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | US20110081342 Anti-vegf antibodies |